Global In-vitro Lung Model Market Key Players Competitive Survey Report 2023

Report ID: ARS3088 | Category: Agriculture | Pages: 96 | Format: PDF | Published Date: September 07,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3650.00 Multi User-$6200.00

Report Description
View Table of Contents

Report Summary

The global In-vitro Lung Model market size in 2022 is 321.2 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 16.80% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the In-vitro Lung Model market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), and InSphero (Switzerland). The share of the top 3 players in the In-vitro Lung Model market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of In-vitro Lung Model market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. 2D Cell Models accounted for XX% of In-vitro Lung Model market in 2022. 3D Cell Models share of XX%.
Drug Screening accounted for XX% of the In-vitro Lung Model market in 2022. Toxicology accounts for XX%.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global In-vitro Lung Model market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.

The report analyzes the key trends in each segment of the global In-vitro Lung Model market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.

Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the In-vitro Lung Model market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global In-vitro Lung Model market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the In-vitro Lung Model industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.

Digital technology is becoming more and more popular in agricultural value chain
Digital technology is becoming more and more popular in agricultural value chain, which reduces information asymmetry, improves transparency and raises output to a new high. So far, agricultural technology has promoted the development of agriculture in four "times" and continues to determine the maturity of producing countries.
For example, in terms of corn production, Africa and India are still in the first stage, known as the Green Revolution, which is characterized by the use of fertilizers and pesticides. Argentina, Brazil and China are in the stage of modern agriculture, which involves a new generation of crop protection products and new farming methods, such as mechanization. The European Union and the United States have developed into the 21st century agriculture characterized by precision agriculture-for example, using advanced analytical techniques to apply nutrients and crop protection products in different proportions.
In the next few years, only the producers who master precision agriculture can be ready to use the fourth era, that is, the next generation of agricultural technology. Although it is still far away, this era will be characterized by the the proliferation of biotechnologies, gene editing (such as CRISPR), and automation, including agricultural robots that will monitor fields and harvest crops.

Highlights-Regions

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia

Player list
Epithelix (Switzerland)
MatTek Corporation (US)
Lonza (Switzerland)
ATCC (US)
InSphero (Switzerland)
Emulate (US)
AlveoliX (Switzerland)
Oncotheis (Switzerland)
Insphero (Switzerland)
TissUse (Switzerland)
Mimetas (Netherlands)
and CN Bio Innovations (UK).

Types list
2D Cell Models
3D Cell Models

Application list
Drug Screening
Toxicology
Others

Table of Content

1 In-vitro Lung Model Market Introduction and Overview
1.1 In-vitro Lung Model Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global In-vitro Lung Model Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global In-vitro Lung Model Revenue and Market Share by Type
3 Global In-vitro Lung Model Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global In-vitro Lung Model Revenue Market Share by Application (2018-2023)
4 Global Market Growth Trends Analysis
4.1 Global In-vitro Lung Model Market Size (2018-2023)
4.2 In-vitro Lung Model Growth Trends Analysis by Regions
4.2.1 In-vitro Lung Model Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 In-vitro Lung Model Historic Revenue Market Size by Regions (2018-2023)
4.2.3 North America In-vitro Lung Model Market Size (2018-2023)
4.2.4 Europe In-vitro Lung Model Market Size (2018-2023)
4.2.5 Asia-Pacific In-vitro Lung Model Market Size (2018-2023)
4.2.6 Latin America In-vitro Lung Model Market Size (2018-2023)
4.2.7 Middle East & Africa In-vitro Lung Model Market Size (2018-2023)
5 North America
5.1 North America In-vitro Lung Model Revenue by Countries
5.1.1 North America In-vitro Lung Model Revenue by Countries (2018-2023)
5.2 North America In-vitro Lung Model Revenue by Types
5.3 North America In-vitro Lung Model Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific In-vitro Lung Model Revenue by Countries
6.1.1 Asia Pacific In-vitro Lung Model Revenue by Countries (2018-2023)
6.2 Asia Pacific In-vitro Lung Model Revenue by Types
6.3 Asia Pacific In-vitro Lung Model Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe In-vitro Lung Model Revenue by Countries
7.1.1 Europe In-vitro Lung Model Revenue by Countries (2018-2023)
7.2 Europe In-vitro Lung Model Revenue by Types
7.3 Europe In-vitro Lung Model Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America In-vitro Lung Model Revenue by Countries
8.1.1 Latin America In-vitro Lung Model Revenue by Countries (2018-2023)
8.2 Latin America In-vitro Lung Model Revenue by Types
8.3 Latin America In-vitro Lung Model Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa In-vitro Lung Model Revenue by Countries
9.1.1 Middle East & Africa In-vitro Lung Model Revenue by Countries (2018-2023)
9.2 Middle East & Africa In-vitro Lung Model Revenue by Types
9.3 Middle East & Africa In-vitro Lung Model Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global In-vitro Lung Model Market Competition, by Players
10.1 Global In-vitro Lung Model Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 In-vitro Lung Model Players Market Share in 2022
10.2.2 Top 6 In-vitro Lung Model Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 In-vitro Lung Model Players Head Office, Business Provided
10.4 In-vitro Lung Model Mergers & Acquisitions
10.5 In-vitro Lung Model New Entrants and Expansion Plans
11 Players Profiles11.1 Epithelix (Switzerland)
11.1.1 Epithelix (Switzerland) Company Profile
11.1.2 In-vitro Lung Model Product Overview
11.1.3 Epithelix (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
11.1.4 Epithelix (Switzerland) Business Overview
11.1.5 Recent Developments and Plans
11.2 MatTek Corporation (US)
11.2.1 MatTek Corporation (US) Company Profile
11.2.2 In-vitro Lung Model Product Overview
11.2.3 MatTek Corporation (US) In-vitro Lung Model Market Performance (2018-2023)
11.2.4 MatTek Corporation (US) Business Overview
11.2.5 Recent Developments and Plans
11.3 Lonza (Switzerland)
11.3.1 Lonza (Switzerland) Company Profile
11.3.2 In-vitro Lung Model Product Overview
11.3.3 Lonza (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
11.3.4 Lonza (Switzerland) Business Overview
11.3.5 Recent Developments and Plans
11.4 ATCC (US)
11.4.1 ATCC (US) Company Profile
11.4.2 In-vitro Lung Model Product Overview
11.4.3 ATCC (US) In-vitro Lung Model Market Performance (2018-2023)
11.4.4 ATCC (US) Business Overview
11.4.5 Recent Developments and Plans
11.5 InSphero (Switzerland)
11.5.1 InSphero (Switzerland) Company Profile
11.5.2 In-vitro Lung Model Product Overview
11.5.3 InSphero (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
11.5.4 InSphero (Switzerland) Business Overview
11.5.5 Recent Developments and Plans
11.6 Emulate (US)
11.6.1 Emulate (US) Company Profile
11.6.2 In-vitro Lung Model Product Overview
11.6.3 Emulate (US) In-vitro Lung Model Market Performance (2018-2023)
11.6.4 Emulate (US) Business Overview
11.6.5 Recent Developments and Plans
11.7 AlveoliX (Switzerland)
11.7.1 AlveoliX (Switzerland) Company Profile
11.7.2 In-vitro Lung Model Product Overview
11.7.3 AlveoliX (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
11.7.4 AlveoliX (Switzerland) Business Overview
11.7.5 Recent Developments and Plans
11.8 Oncotheis (Switzerland)
11.8.1 Oncotheis (Switzerland) Company Profile
11.8.2 In-vitro Lung Model Product Overview
11.8.3 Oncotheis (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
11.8.4 Oncotheis (Switzerland) Business Overview
11.8.5 Recent Developments and Plans
11.9 Insphero (Switzerland)
11.9.1 Insphero (Switzerland) Company Profile
11.9.2 In-vitro Lung Model Product Overview
11.9.3 Insphero (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
11.9.4 Insphero (Switzerland) Business Overview
11.9.5 Recent Developments and Plans
11.10 TissUse (Switzerland)
11.10.1 TissUse (Switzerland) Company Profile
11.10.2 In-vitro Lung Model Product Overview
11.10.3 TissUse (Switzerland) In-vitro Lung Model Market Performance (2018-2023)
11.10.4 TissUse (Switzerland) Business Overview
11.10.5 Recent Developments and Plans
11.11 Mimetas (Netherlands)
11.11.1 Mimetas (Netherlands) Company Profile
11.11.2 In-vitro Lung Model Product Overview
11.11.3 Mimetas (Netherlands) In-vitro Lung Model Market Performance (2018-2023)
11.11.4 Mimetas (Netherlands) Business Overview
11.11.5 Recent Developments and Plans
11.12 and CN Bio Innovations (UK).
11.12.1 and CN Bio Innovations (UK). Company Profile
11.12.2 In-vitro Lung Model Product Overview
11.12.3 and CN Bio Innovations (UK). In-vitro Lung Model Market Performance (2018-2023)
11.12.4 and CN Bio Innovations (UK). Business Overview
11.12.5 Recent Developments and Plans
12 Global In-vitro Lung Model Forecast Market Analysis by Type
12.1 Global In-vitro Lung Model Revenue Market Forecast by Type (2023-2029)
13 Global In-vitro Lung Model Forecast Market Analysis by Application
13.1 In-vitro Lung Model Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Analysis
14.1 Global In-vitro Lung Model Forecast Market Size (2023-2029)
14.2 In-vitro Lung Model Growth Trends Forecast Analysis by Regions
14.2.1 In-vitro Lung Model Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America In-vitro Lung Model Forecast Market Size (2023-2029)
14.2.3 Europe In-vitro Lung Model Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific In-vitro Lung Model Forecast Market Size (2023-2029)
14.2.5 Latin America In-vitro Lung Model Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa In-vitro Lung Model Forecast Market Size (2023-2029)
15 In-vitro Lung Model Industry Dynamic Analysis
15.1 In-vitro Lung Model Market Trends Analysis
15.2 In-vitro Lung Model Market Drivers Analysis
15.3 In-vitro Lung Model Market Challenges Analysis
15.4 In-vitro Lung Model Market Restraints Analysis

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global In-vitro Lung Model Market Key Players Competitive Survey Report 2023

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?